In the News

By Grace Seger; The New Republic The senator spoke to TNR about how he’ll grill the CEOs of three drug manufacturers about their high prices. Since taking the helm of the committee that oversees the nation’s health care system last year, Senator Bernie Sanders has used his perch to take aim at pharmaceutical executives over the cost of prescription drugs.

By Gabriel Debenedetti; New York Magazine He’s getting louder about America’s role in Israel’s war, pushing his own party to act before it’s too late. Bernie Sanders has been thinking a lot these days about what public pressure can accomplish when it comes to the war in Gaza. We were talking less than 24 hours after Joe Biden had struggled to make

By Calvin Cutler; WCAX BURLINGTON, Vt. (WCAX) – What can the federal government do to make emergency medical services sustainable? Across Vermont, EMS providers and other agencies are stretched thin with staff shortages, low wages, burnout, and low reimbursement rates. Many of those agencies are also on the front lines of responding to the opioid crisis. Vermont Senator Bernie Sanders

By: Caitlin Yilek; CBS News Washington — Sen. Bernie Sanders of Vermont said Sunday that Israel is “losing the war” of worldwide public opinion as it seeks to eradicate Hamas in the aftermath of the Oct. 7 attack.  Sanders, an independent who caucuses with Democrats, told “Face the Nation” that Israel has the “right to defend itself” against Hamas, but it “cannot

By: Analysis by McKenzie Beard with research by Rachel Roubein; Washington Post It took the Senate 175 days to confirm Monica Bertagnolli as the next leader of the National Institutes of Health after President Biden first nominated her for the role — largely because of Sen. Bernie Sanders (I-Vt.), who blocked her nomination until he was able to extract a White House commitment to lower drug prices. The pressure campaign

By Nathaniel Weixel; The Hill Sen. Bernie Sanders (I-Vt.) said he is confident that forcing drug company CEOs to testify about high prices can result in meaningful changes.  Less than a week ahead of a planned vote to subpoena the CEOs of Johnson & Johnson and Merck, the chair of the Senate Health, Education, Labor and Pensions Committee said having them testify